Menu Search
Equities

CeriBell Inc

CBLL:NSQ

CeriBell Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)28.25
  • Today's Change0.37 / 1.33%
  • Shares traded26.56k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 16:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year CeriBell Inc grew revenues 74.47% from 25.92m to 45.23m while net income improved from a loss of 37.16m to a smaller loss of 29.46m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at CeriBell Inc fell by 33.74m. Cash Flow from Investing was negative at 1.76m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 29.16m for operations while cash used for financing totalled 2.82m.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.5919
Tangible book value per share0.5919
More ▼

Balance sheet in USDView more

CeriBell Inc appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio4.08
Quick ratio3.53
Total debt/total equity0.9653
Total debt/total capital0.4912
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.